Antiviral

Virologic response associates with better quality of life in hepatitis C

Published in Hepatitis Weekly, April 15th, 2002

by Sonia Nichols, senior medical writer - Sustained virologic response is crucial for improving the quality of life and getting patients with chronic hepatitis C to adhere to their treatment regimens better, scientists in the U.S. report.

One way to do this may be to prescribe for them peginterferon, which according to some studies has been more effective than standard interferon (IFN)-alfa for improving viral response in hepatitis C virus (HCV)-positive patients.

In a study supported by Hoffmann-La Roche, David Bernstein, North Shore University Hospital, Manhasset, New York, collaborated with personnel at other centers to assess quality of life and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2002-04-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry